MyAverix Finance
SHE · Healthcare
Chengdu Kanghua Biological Products (300841)
Biotechnology
Chengdu Kanghua Biological Products (300841) is listed on SHE in the Healthcare sector. Industry: Biotechnology. As of 2026-03-28, reported market cap is $7.36B, P/E ratio is 39.89, net margin is 15.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 300841
Chengdu Kanghua Biological Products (300841) — FAQ
What is Chengdu Kanghua Biological Products's market cap?
Chengdu Kanghua Biological Products (300841) has a reported market cap of $7.36B (data as of 2026-03-28).
What is 300841's P/E ratio?
The price-to-earnings (P/E) ratio for Chengdu Kanghua Biological Products (300841) is 39.89 (data as of 2026-03-28).
Does Chengdu Kanghua Biological Products pay a dividend?
Dividend yield is not available in the current snapshot for Chengdu Kanghua Biological Products (300841). Check the MyAverix Finance app for the latest dividend data.
What sector is Chengdu Kanghua Biological Products in?
Chengdu Kanghua Biological Products (300841) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 300841 listed on?
300841 is listed on SHE.
What is Chengdu Kanghua Biological Products's net margin?
Chengdu Kanghua Biological Products (300841) reports a net margin of 15.0% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.